Canadian ciprofloxacin susceptibility study: Comparative study from 15 medical centers

J. M. Blondeau; Y. Yaschuk; J. A. Smith; M. A. Noble; P. Kibsey; G. B. Horsman; D. J. Hoban; W. D. Colby; P. Jessamine; A. E. Simor; D. E. Low; A. M. Bourgault; M. Laverdiere; M. Kuhn; S. MacDonald; W. Brown

Journal ArticleOPEN ACCESS

Canadian ciprofloxacin susceptibility study: Comparative study from 15 medical centers

Blondeau J
Yaschuk Y
Smith J
et al.

Antimicrobial Agents and Chemotherapy (1996) 40(7) 1729-1732

DOI: 10.1128/aac.40.7.1729

29Citations

5Readers

Abstract

We tested 4,507 microorganisms, from 15 Canadian medical centers, against ciprofloxacin and several other antimicrobial agents to determine the in vitro susceptibilities. Overall, susceptibility of members of the family Enterobacteriaceae to ciprofloxacin was 97%; Moraxella and Haemophilus spp. had susceptibilities of 98 and 99%, respectively; and P. aeruginosa and S. aureus had susceptibilities of 79 and 96%, respectively.

Cite

CITATION STYLE

APA

Blondeau, J. M., Yaschuk, Y., Smith, J. A., Noble, M. A., Kibsey, P., Horsman, G. B., … Brown, W. (1996). Canadian ciprofloxacin susceptibility study: Comparative study from 15 medical centers. Antimicrobial Agents and Chemotherapy, 40(7), 1729–1732. https://doi.org/10.1128/aac.40.7.1729

Canadian ciprofloxacin susceptibility study: Comparative study from 15 medical centers

Abstract

Cite

Register to see more suggestions